Skip to content
Compare prices

Independent UK medicine guidance

Mounjaro and contraception: does it affect the pill?

If you take an oral contraceptive and you are overweight or living with obesity, Mounjaro's UK product information asks you to do one of two things: add a barrier method such as condoms for four weeks after your first dose and for four weeks after every dose increase, or move to a non-oral method for the duration of treatment. The reason is absorption, not hormones. Tirzepatide slows the stomach, and a slower stomach delivers the pill's ingredients to the bloodstream later and at a lower peak. This guide explains the rule, the evidence behind it, what to do after a bout of sickness, and why the pregnancy advice matters more than most people realise.

Written by: Nick Johnson, Independent Prescription Pricing Analyst, Medstack Ltd  |  Checked: 14 September 2026  |  Next scheduled review: 14 December 2026

Key facts

  • The four-week rule applies to oral contraceptives only, in people who are overweight or have obesity. Implants, injections, coils, patches and rings are not affected by stomach emptying.
  • It restarts after every dose increase, not just at the beginning of treatment.
  • The MHRA restated this advice in its GLP-1 safety guidance of 5 June 2025, alongside a reminder that these medicines must not be used in pregnancy or while trying to conceive.
  • Vomiting or severe diarrhoea can stop a pill being absorbed on its own; follow the missed-pill rules for your brand.
  • Planning a pregnancy means stopping tirzepatide at least one month beforehand, arranged with your prescriber.
Several blister packs of oral contraceptive pills in different colours fanned out on a white background
Every kind of oral contraceptive, combined or progestogen-only, is covered by the four-week precaution, because the concern is how quickly the tablet is absorbed rather than which hormone it contains. Photograph by Medstack Ltd.
Think you might be pregnant?Stop Mounjaro and contact your prescriber or GP straight away. Do not wait for a routine appointment.
Unprotected sex after vomiting or a missed pill?Emergency contraception is time-sensitive. A pharmacy or sexual health service can advise the same day.

The four-week rule, in full

What the product information says. Patients who are overweight or have obesity and use oral hormonal contraceptives should either switch to a non-oral contraceptive method, or add a barrier method of contraception for four weeks after starting tirzepatide and for four weeks after each dose increase.

In practice that gives you two routes:

  • Keep the pill and add condoms. Use a barrier method from the day of your first injection until four weeks later, then again from each dose increase for another four weeks. On the standard escalation path that can mean a barrier method for much of the first six months, which is why many people find the second route simpler.
  • Switch to a non-oral method. The implant, the contraceptive injection, a hormonal or copper coil, the patch or the vaginal ring are all unaffected by stomach emptying. Each takes a different length of time to become effective and some need a fitting appointment, so arrange the switch before you start Mounjaro if you can, with a GP, pharmacist or sexual health clinic.

The clock resets at every dose increase. If you go up a dose without adding a barrier method for the following four weeks, you are outside the product information's advice for that period.

Why a weekly injection can affect a daily tablet

Tirzepatide delays gastric emptying, and the delay is greatest in the first weeks after starting and after each step up in dose, easing as the body adapts. Any tablet that relies on passing promptly from the stomach into the small intestine to be absorbed can be affected. In the manufacturer's interaction studies, a single 5mg dose of tirzepatide reduced the peak blood concentration of the components of a combined oral contraceptive and delayed the time at which that peak was reached, without a large change in the total amount absorbed.

What that means for real-world contraceptive failure has not been measured directly. The product information says a reduction in effectiveness cannot be ruled out in patients who are overweight or have obesity, and the precaution exists to cover that uncertainty rather than because failures have been proven. The MHRA repeated the advice in its June 2025 guidance and noted that it had received Yellow Card reports of pregnancies in women using GLP-1 medicines, which is one reason the regulator chose to remind patients publicly.

Does this apply to the mini pill?

The interaction study used a combined pill, but the product information's precaution covers oral hormonal contraceptives as a group, and the mechanism, slower absorption from the stomach, applies to any tablet. Progestogen-only pills also have narrower timing windows than combined pills, so an absorption delay is at least as relevant. Treat the four-week rule as applying to the mini pill too, and ask a pharmacist or sexual health professional if you want a method that removes the question altogether.

Vomiting, diarrhoea and missed pills

Nausea, vomiting and diarrhoea are among the most common Mounjaro side effects, and each can independently stop an oral contraceptive from being absorbed. Being sick within a few hours of taking a pill, or having severe diarrhoea, is treated by most brands as a missed pill.

  • Follow the missed-pill and sickness instructions in your contraceptive's leaflet. They differ between combined and progestogen-only pills and between brands.
  • If you are unsure, ask a pharmacist. Most can advise on missed pills and supply emergency contraception without an appointment.
  • If you have had unprotected sex during a period when the pill may not have worked, do not wait: emergency contraception is most effective the sooner it is taken.
  • If sickness is persistent, tell your prescriber. Dose escalation is meant to depend on how you tolerate the current dose, and it may be sensible to stay on it longer.

Emergency contraception is time-limited, so seek advice the same day rather than at your next routine appointment.

Pregnancy, fertility and Mounjaro

Mounjaro must not be used during pregnancy or while trying to conceive, because there is not enough safety data to know whether it can harm a baby. If you become pregnant during treatment, stop the medicine and speak to your prescriber or GP as soon as possible. Breastfeeding is a separate conversation with your prescriber: the MHRA's June 2025 guidance advised against it, and the current product information treats it as a case-by-case decision weighing benefit against any potential risk to the infant.

If you are planning a pregnancy, the product information says tirzepatide should be stopped at least one month before you try, because of its long half-life. Arrange that with your prescriber, particularly if you use Mounjaro for diabetes and need an alternative plan for blood sugar.

Do not treat weight loss, irregular periods or a history of difficulty conceiving as contraception. As weight falls and metabolic health improves, ovulation can return in people who had not been ovulating regularly, so fertility can rise during treatment. That is exactly when reliable contraception matters most.

Common questions

Does Mounjaro stop the pill working?

The product information does not say the pill stops working. It says a reduced effect cannot be ruled out in people who are overweight or have obesity, because tirzepatide slows stomach emptying and lowers the peak absorption of the pill's ingredients. The precaution is to add a barrier method for four weeks after starting Mounjaro and after every dose increase, or to switch to a non-oral method.

Why does the four-week rule apply after every dose increase?

Because the delay in stomach emptying is greatest when a dose is new and eases as the body adapts. Each step up in dose brings the effect back, so the product information repeats the precaution after every increase, not only at the start of treatment.

Does the rule apply to the coil, implant, patch or injection?

No. Those methods do not pass through the stomach, so slower gastric emptying does not affect them. The precaution is specific to oral contraceptives. Switching to one of these methods is the alternative the product information offers to using condoms for four weeks at a time.

Can I take Mounjaro while trying to conceive?

No. Mounjaro must not be used while trying to become pregnant or during pregnancy. If you are planning a pregnancy, the product information says tirzepatide should be stopped at least one month beforehand, arranged with your prescriber. Do not rely on weight loss, irregular periods or reduced fertility as contraception, as fertility can improve as weight and metabolic health change.

What if I was sick shortly after taking my pill?

Treat it as your contraceptive's leaflet instructs, which for most brands means treating it as a missed pill. A pharmacist can confirm the rule for your brand, advise on extra precautions and supply emergency contraception if you have had unprotected sex.

How this page was checked. The four-week precaution and the interaction study description are taken from sections 4.5 and 4.6 of the Mounjaro KwikPen Summary of Product Characteristics on the eMC (record 15481). The regulator's position is taken from the MHRA's guidance "GLP-1 medicines for weight loss and diabetes: what you need to know", published 5 June 2025. Monj is an independent price comparison service and does not prescribe or dispense medicines, and nothing here replaces advice from your own prescriber, pharmacist or sexual health service. Corrections go through our editorial and review policy.

Related guides

Sources: Mounjaro KwikPen Summary of Product Characteristics, sections 4.5 and 4.6 (eMC) • Mounjaro KwikPen UK Patient Information Leaflet (eMC) • MHRA: GLP-1 medicines for weight loss and diabetes, what you need to know (5 June 2025) • NHS: Tirzepatide • NHS: Contraception

Explore other side effects

Tap a point on the body to jump to that symptom, or choose from the full list below. The pink marker shows where you are now.

Open the full interactive symptom map

© 2026 Medstack Ltd. Written and published by Monj (monj.co.uk). You are welcome to link to this page or quote a short extract with a credit and a link. Republishing the text, page structure, safety-routing design or price data, in whole or in part, including to train or ground an automated system, is not permitted without written permission. See our independence statement and editorial and review policy.

Sources referenced on this page

Monj is an independent price comparison index operated by Medstack Ltd. We are not a pharmacy and we do not sell, prescribe, supply or dispense medicines. Listings are ranked strictly by the lowest total patient price, with alphabetical order used to break ties. No pharmacy can pay for placement, ranking or badges. Some outbound links earn a referral commission, and this never affects position or inclusion. Read the full independence statement.